Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 569.76B, Johnson & Johnson(JNJ) trades at $236.55. The stock has a price-to-earnings ratio of 21.61 and currently yields dividends of 2.2%.
On 2026-04-13, Johnson & Johnson(JNJ) stock traded between a low of $235.18 and a high of $239.47. Shares are currently priced at $236.55, which is +0.6% above the low and -1.2% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 3.14M, against a daily average of 6.86M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
JNJ News
The Dow Jones Industrial Average enters the week in the spotlight with four of the 30 component stocks set to report quarterly earnings results this week. Here'...
Johnson & Johnson (JNJ) is expected to report a 3.2% fall in its first-quarter earnings, due on April 14, before the opening bell. The consensus EPS estimate i...
Healthcare stock Johnson & Johnson (JNJ) is set to report its Q1 earnings tomorrow – April 14. The stock is up nearly 16% in the year-to-date helped by demand f...
Analyst ratings
59%
of 29 ratingsMore JNJ News
Markets Goldman Sachs, Bank of America, JP Morgan, Netflix, J&J, Producer Prices, and More to Watch This Week In this article GS BAC MS NFLX Stocks enjoyed a se...
Key Points Johnson & Johnson is one of the largest pharmaceutical stocks by market cap. Pfizer's dividend offers a hefty yield. Revenue is growing for J&J, w...
Key Points Johnson & Johnson is facing lawsuits, patent cliffs, and disruptive drug pricing negotiations. Despite that, the company's revenue continues to gro...
Key Points Johnson & Johnson has an incredible dividend-increase streak spanning more than 60 years. The company's business is diversified beyond drugs, provi...
If you are wondering whether Johnson & Johnson at around US$241 a share is still reasonably priced or already stretched, the next sections will walk through wha...
Johnson & Johnson (NYSE:JNJ) will release earnings for its first quarter before the opening bell on Tuesday, April 14. Analysts expect the New Brunswick, New J...
Advertisement Royalty Pharma (RPRX) is back in focus after announcing a US$500 million R&D co funding agreement with Johnson & Johnson to advance JNJ-4804, an...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.